Navigation Links
Cell Biosciences Launches New Platform for Multiplex Western Blot Detection
Date:1/5/2011

SANTA CLARA, Calif., Jan. 5, 2011 /PRNewswire/ -- Cell Biosciences, Inc., a provider of innovative protein analysis tools to life science researchers, today announced the launch of the latest addition to their premier line of next-generation imaging products, the FluorChem® M MultiFluor system. This new platform combines highly-sensitive quantitative detection of multicolor fluorescent Western blots with key ease-of-use features aimed at simplifying the laboratory imaging process. MultiFluor Western Blotting kits, a new line of reagents optimized for the FluorChem M, are launching jointly - creating a combined offering that provides a complete solution for multicolor fluorescent imaging.

Multiplex capability enables scientists to obtain more information in a single Western blot than chemiluminescence imaging or film, while also providing greater dynamic and linear range. Multiple proteins can be detected simultaneously and proteins with co-migration patterns are revealed immediately. Additionally, the need to strip and reprobe blots for subsequent detection of other proteins is eliminated, which minimizes protein loss and results in shorter assay times and higher data integrity.  

"The new FluorChem platforms integrate high-performance imaging with true ease of operation, facilitating the transition from darkroom film imaging to bench-top imager," commented Tim Harkness, President and Chief Executive Officer of Cell Biosciences. "Customer response to FluorChem E, our initial market entry in this product line, has been tremendously positive. We sold over 100 FluorChem E units in the first six months, and we believe that FluorChem M will be a key driver for the continued growth of our imaging line."

FluorChem M features intuitive software, touchscreen operation and pre-optimized protocols that let researchers start imaging right out of the box – no training required. Using a unique browser-based interface, scientists can control
'/>"/>

SOURCE Cell Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Frost & Sullivan Presents the 2010 North American Enabling Technology of the Year Award for Surface Functionalization Technologies to Semprus BioSciences
2. Ambit Biosciences Initiates Two Phase I Clinical Trials
3. Catalyst Biosciences Receives Milestone Payment from Pfizer for Progress in Lead Hemostasis Program
4. Cell Biosciences Announces US Patent Issuance
5. Sofie Biosciences Raises $2M to Support Development of Diagnostic Imaging Agents and Devices
6. Sangamo BioSciences Announces Presentation of Phase 2 Data in Amyotrophic Lateral Sclerosis (ALS) at Society for Neuroscience Meeting
7. Regado Biosciences, Inc. Introduces REG3, a Novel Aptamer-Based Inhibitor of Glycoprotein VI and its Matched Active Control Agent, at the American Heart Association (AHA) Scientific Sessions 2010 Meeting
8. Cardio3 BioSciences Announces Positive Outcome of the C-Cure(R) Phase II Clinical Trial in Heart Failure Patients
9. Regado Biosciences, Inc. Presents Pharmacokinetic and Pharmacodynamic (PK/PD) Substudy Results From its Phase 2b RADAR Trial at the American Heart Association (AHA) Scientific Sessions 2010 Meeting
10. Regado Biosciences, Inc. Presents Two Abstracts on the Subcutaneous Depot Formulation of Pegnivacogin, a Nuclease-Stabilized RNA Aptamer, Direct Factor IXa Inhibitor and Part of the REG2 Anticoagulant System, at the American Heart Association (AHA)
11. Magellan Biosciences to Debut Revolutionary New Dynex® Clinical Diagnostics Processing System for Fully Automated ELISA Testing at MEDICA 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... , July 14, 2014  Mallinckrodt plc (NYSE: ... QCOR ) today announced that the registration statement on Form ... by Mallinckrodt plc on May 16, 2014 and amended on ... Mallinckrodt and Questcor that also constitutes a prospectus of Mallinckrodt, ... on Form S-4 is available on the SEC,s EDGAR system, ...
(Date:7/14/2014)... -- BioAdaptives, Inc. (OTCBB:BDPT) is pleased to announce Mr. ... of President and CEO of the Company.  Mr. Epling ... that licensed its formulation, intellectual properties, and other technologies ... "Mr. Gerald Epling , who has been ... held entity to a public company, has decided to ...
(Date:7/13/2014)... -- Eli Lilly and Company (NYSE: LLY ... in genetically engineered mice examining combination therapy with ... and beta-secretase inhibitor BACE (LY2811376). Data results found ... clumps of amyloid-beta protein in the brain – ... Alzheimer,s disease (AD) – than use of one ...
Breaking Medicine Technology:Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Provide Update On Transaction 2Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Provide Update On Transaction 3Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Provide Update On Transaction 4Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Provide Update On Transaction 5Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Provide Update On Transaction 6Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Provide Update On Transaction 7BioAdaptives Prepares for Next Step 2New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice 2New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice 3
(Date:7/14/2014)... pathologist Lukas Kenner and his colleagues have developed a ... tissue sections and demonstrate the presence of specific biomarkers ... of the disease and leads to the most suitable ... study, "Two independent pathologists concur with each other only ... developed software offers, for the first time, the option ...
(Date:7/14/2014)... July 14, 2014 Last month Bromell ... their website. The webpage features more detailed information on ... including motorcycles, RVs, ATVs, and boats in the state ... this new feature to the website in order to ... helps encompass the purpose of the website, which is ...
(Date:7/14/2014)... is he who "begins to age". But laboratory biology ... not a synonym of ageing, it is also not ... a badly named physiological process that those who do ... That is the case of Manuel Serrano, from the ... world,s leading experts on senescence, who has just published ...
(Date:7/14/2014)... may buffer some of the adverse health effects of ... researchers from the American Cancer Society, The Cooper Institute, ... the journal Mayo Clinic Proceeding s, and finds ... blood markers associated with cardiovascular disease is markedly less ... has been linked to an increase risk of obesity, ...
(Date:7/14/2014)... Botanica Day Spa announced last month that their ... the day spa in down town Clearwater, FL on ... refreshments will be served as clients are invited to ... and great deals on spa services, including the ... (also known as “facial shaving”) is a simple and ...
Breaking Medicine News(10 mins):Health News:Scientists developed new technology for the diagnosis of cancer cells 2Health News:Manuel Serrano proposes a new vision of a process wrongly associated with ageing 2Health News:Manuel Serrano proposes a new vision of a process wrongly associated with ageing 3Health News:Physical fitness associated with less pronounced effect of sedentary behavior 2Health News:Botanica Day Spa to Feature Dermaplaning at Upcoming Open House 2Health News:Botanica Day Spa to Feature Dermaplaning at Upcoming Open House 3
... mortality for hospitalized patients, study found , , TUESDAY, Oct. ... hospitalized for pneumonia was one-third lower for those taking ... a Danish study found. , While the findings are ... doctors can prescribe statins as infection fighters, experts said. ...
... Intentional Interference with ... Prospective Business Advantage, CAMBRIDGE, Mass., Oct. ... it had filed an action for injunctive,relief and damages against ... Hemopure, hemoglobin glutamer-250,(bovine), Biopure,s oxygen therapeutic product for human use. ...
... ... Cost Reduction Efforts Continue to Generate Results ... Step for Visian Toric ICL Application to ... FDA, MONROVIA, Calif., Oct. 28 STAAR ...
... disease rises as the joint ailment worsens, research shows ... (RA) may increase the risk of gum disease, a ... link between RA and periodontal disease, a condition where ... from the gums, loss of bony support, and possible ...
... 28 Blue Mountain Quality,Resources, Inc. announced ... Regulatory Asset Manager(R) to satisfy their immediate ... their enterprise-wide,SAP(R) implementation., "Alexion is committed ... in,its manufacturing facilities and other operations," explains ...
... 28 NASA satellite data can,improve forecasts of ... that can,benefit public health managers. Scientists announced the ... (Logo: http://www.newscom.com/cgi-bin/prnh/20081007/38461LOGO ), Led by ... Mexico in,Albuquerque, and William Sprigg of the University ...
Cached Medicine News:Health News:Statins Reduced Death Risk From Pneumonia 2Health News:Statins Reduced Death Risk From Pneumonia 3Health News:Biopure Sues National Institutes of Health Official 2Health News:Biopure Sues National Institutes of Health Official 3Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 2Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 3Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 4Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 5Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 6Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 7Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 8Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 9Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 10Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 11Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 12Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 13Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 14Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 15Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 16Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 17Health News:STAAR Surgical Reports 33% Third Quarter Revenue Growth 18Health News:Rheumatoid Arthritis May Harm Gums 2Health News:Alexion Pharmaceuticals Chooses Blue Mountain Regulatory Asset Manager(R) for Best-in-class Calibration Management Integrated with SAP(R) 2Health News:NASA-Enhanced Dust Storm Predictions to Aid Health Community 2Health News:NASA-Enhanced Dust Storm Predictions to Aid Health Community 3
Measures up to 152 mm in 1 mm increments and 6 inches in 1/32 inch increments. Deeply etched graduations and dull finish....
Endoscopes are also available in fully autoclavable models in 1.8, 2.7, 4.0. 5.0 and 10.0 mm diameters. Manufactured with precise swiss lenses. Built-in temperature measuring device to exactly determ...
Endoscopes are also available in fully autoclavable models in 1.8, 2.7, 4.0. 5.0 and 10.0 mm diameters. Manufactured with precise swiss lenses. Built-in temperature measuring device to exactly determ...
Kleinert-Kutz Single Skin Hook, Large...
Medicine Products: